Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Prostatic Neoplasms, Castration-Resistant
×
Docetaxel
×
Clear all
Filters
3
NCT07225946
2026-03-13
KLK2-PASenger
Janssen Research & Development, LLC
Phase 3
Recruiting
800 enrolled